Related Experiment Video
Updated: Apr 25, 2026

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
Vancomycin blocks autophagy and induces interleukin-1β release in macrophages
Young Eun Ha1, Kyoung-Hye Kong2, Mi-Hyang Cho2
1Samsung Medical Center, Department of Infectious Diseases, Sungkyunkwan University School of Medicine, Seoul, Korea.
Abstract:
Systemic inflammatory response syndrome (SIRS) is a serious condition that can cause organ failure as an exaggerated immunoresponse to the infection or other causes. Recently, autophagy was reported as a key process that regulates inflammatory responses in macrophages. Vancomycin is one of the most commonly prescribed antibiotics for sepsis treatment or following surgery. However, there are no studies on how vancomycin affects autophagy or inflammation. Here, we treated macrophage cell lines with vancomycin and lipopolysaccharides and found that vancomycin blocks autophagy and increases inflammatory responses. This finding suggests that vancomycin should be more cautiously administered in order to prevent unwanted SIRS during sepsis.
Insights
Vancomycin, an antibiotic, blocks autophagy and worsens inflammation in macrophages. This suggests cautious use of vancomycin to prevent systemic inflammatory response syndrome (SIRS) during sepsis.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- Systemic inflammatory response syndrome (SIRS) involves exaggerated immune responses and can lead to organ failure.
- Autophagy is a critical cellular process regulating inflammatory responses in macrophages.
- Vancomycin is a widely used antibiotic for sepsis and post-surgery, but its effect on autophagy and inflammation is unknown.
Purpose of the Study:
- To investigate the impact of vancomycin on autophagy and inflammatory responses in macrophages.
- To explore the potential role of vancomycin in modulating SIRS.
Main Methods:
- Macrophage cell lines were treated with vancomycin and lipopolysaccharides.
- Autophagy levels and inflammatory markers were assessed.
Main Results:
- Vancomycin was found to inhibit autophagy in macrophages.
- Vancomycin treatment led to increased inflammatory responses.
- This suggests a potential exacerbation of SIRS.
Conclusions:
- Vancomycin interferes with autophagy, a key regulator of inflammation.
- This interference may contribute to increased inflammatory responses, potentially worsening SIRS.
- Cautious administration of vancomycin is recommended in sepsis patients to mitigate adverse inflammatory effects.
More Related Videos
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Cellular Injury V: Apoptosis and Autophagy
Drugs that Destabilize Microtubules

